Cabaletta Bio, Inc. (CABA) Misses Q2 EPS by 1c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q2 EPS of ($0.56), $0.01 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• Caterpillar (CAT) PT Raised to $1,105 at Oppenheimer
• Macquarie Downgrades Singapore Exchange (SGX:SP ) (SPXCY) to Neutral